在质母细胞瘤和血管性瘤中非增强瘤之间的区别,使用扩散加权和动态敏感性对比MR成像
Sahar Alizada1, Yasmin Aly2, Hongbo Bao2
1From the Department of Neuroradiology (S.A.), The University of Texas MD Anderson Cancer Center, Houston, Texas.
AJNR. American journal of neuroradiology
|September 18, 2025
概括
扩散和 perfusion MRI,使用明显扩散系数 (ADC) 和相对脑血量 (rCBV),有效地区分非增强性质母细胞瘤和血管性. 这些先进的成像技术为大脑瘤的表征提供了更好的诊断准确性.
科学领域:
- 神经成像是一种神经成像.
- 放射学 放射学是一门学科.
- 在瘤学瘤学.
背景情况:
- 区分非增强性质母细胞瘤与血管性瘤是神经成像中的一个重大挑战.
- 准确的区分对于有效的治疗计划和患者管理至关重要.
研究的目的:
- 为了评估扩散加权成像 (DWI) 和动态敏感性对比 (DSC) MRI 的实用性,特别是明显扩散系数 (ADC) 和相对脑血液体积 (rCBV) 值.
- 使用这些定量MRI参数,区分非增强性质母细胞瘤和血管性.
主要方法:
- 对111名质母细胞瘤患者和可用的预治疗MRI进行了回顾性分析.
- 在固体非增强性质母细胞瘤,非增强性临性T2-FLAIR高强度和血管性瘤之间,ADC和rCBV值的比较.
- 接收器操作特征 (ROC) 分析,以确定最佳的分类值.
主要成果:
- 固体非增强性质母细胞瘤与血管性水相比显示显著较低的ADC和较高的rCBV (P < .001).
- 最佳的ADC和rCBV值实现了优异的灵敏度和特异性,以区分固体非增强性质母细胞瘤与血管性.
- 不增强外周的T2-FLAIR高强度的ADC值类似于血管性胀,但显著高于rCBV (P = .03).
结论:
- 扩散和 perfusion-weighted MRI 参数 (ADC 和 rCBV) 是有价值的生物标志物,用于区分非增强性质母细胞瘤和血管性.
- 确定值可以增强质母细胞瘤的特征和从转移的术前分化.
- 这些发现支持更精确的,图像引导的脑瘤临床管理.
相关概念视频
Assessment of Diffusion and Perfusion
1.5K
Understanding and evaluating diffusion and perfusion is critical in assessing a patient's respiratory and circulatory health. These processes play key roles in maintaining the body's internal environment, ensuring that tissues receive adequate oxygen while waste products are efficiently removed.
The Role of Diffusion in Respiration
Diffusion is the process by which molecules move from an area of higher concentration to an area of lower concentration. In the respiratory system, this...
The Role of Diffusion in Respiration
Diffusion is the process by which molecules move from an area of higher concentration to an area of lower concentration. In the respiratory system, this...
1.5K
Magnetic Resonance Imaging
9.1K
Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
9.1K


